CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

2.86B

Vuru Grade

67.23/100

Current Price

$115.16
+3.67 (+3.29%)

Growth Price

$42.54
Overvalued by 63.06%

Stability Price

$19.81
Overvalued by 82.80%

Company Metrics

  • 39.81 P/E
  • 10.77 P/S
  • 11.7 P/B
  • 2.89 EPS
  • 31.13% Cash ROIC
  • 0.67 Cash Ratio
  • 0 / 0% Dividend
  • 165,970.00 Avg. Vol.
  • 24.84M Shares
  • 2.86B Market Cap.

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products Inc Bearish Signal Wp X Biologics Llc decreased Stake
OctaFinance.com - Jun 16, 2015
Wp X Biologics Llc has filled a SC 13D/A form regarding China Biologic Products, Inc 116.11 -2.98 -2.50% . Filing Link: 000119312515224772.
Form 8-K China Biologic Products, For: Jun 15 - StreetInsider.com
Large Outflow of Money Witnessed in China Biologic Products, Inc.
Insider Trading Report - Jun 24, 2015
China Biologic Products, Inc. (NASDAQ:CBPO) During the most recent session, the shares traded at 2.94 points or 2.52% higher at $119.57.
Stock in Focus - China Biologic Products, Inc. (NASDAQ:CBPO) - Vanguard Tribune
Earnings of $0.85 Expected in Q2 for China Biologic Products, Inc. (NASDAQ ...
Markets Daily - Jun 29, 2015
Sell-side Wall Street analysts are anticipating China Biologic Products, Inc. (NASDAQ:CBPO) will post a current quarter earnings per share of $0.85.
China Biologic Products, Inc. (CBPO) Files Form 4 Insider Selling : David Hui ...
Insider Trading Report - Jun 17, 2015
China Biologic Products, Inc. (CBPO): David Hui Li , director of China Biologic Products, Inc. sold 2,645,000 shares on Jun 15, 2015.
China Biologic Products, Inc. (NASDAQ:CBPO) Price Target Update - American Trade Journal
Stock in Motion: China Biologic Products, Inc. (NASDAQ:CBPO) - Vanguard Tribune
Earnings in Focus: China Biologic Products, Inc. (NASDAQ:CBPO)
Markets Daily - Jun 15, 2015
China Biologic Products, Inc. (NASDAQ:CBPO) is expected to post quarterly earnings on 2015-08-04. Investors will be eagerly eyeing the number the company reports compared to the earnings per share that brokers are predicting.
Brokerage Views on China Biologic Products, Inc. (NASDAQ:CBPO)
Markets Daily - Jun 22, 2015
Sell-side Research analysts on Wall Street that monitor future earnings growth for China Biologic Products, Inc. (NASDAQ:CBPO) are anticipating that the company will post an EPS number of $0.85 for the quarter ending 2015-06-30.
Trade-Ideas: China Biologic Products (CBPO) Is Today's New Lifetime High Stock
TheStreet.com - Mar 20, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products Q4 2014 Earnings: Primed For A Sell-Off? (CBPO)
Seeking Alpha (registration) - Feb 23, 2015
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
China Biologic Products, Inc. (CBPO) Discloses Form 4 Insider Selling : Exec ...
OTC Outlook - Jun 20, 2015
China Biologic Products, Inc. (CBPO) Discloses Insider Transaction. David Hui Li , director of China Biologic Products, Inc. sold 2,645,000 shares on Jun 15, 2015. The Insider selling transaction was disclosed on Jun 17, 2015 to the Securities and ...
New Lifetime High Reached By China Biologic Products (CBPO)
TheStreet.com - Mar 27, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.